Heterogeneity in Economic Value of SGLT2is for Type 2 Diabetes: Subgroup Modeling Cost-Effectiveness Analyses. - Chong KS; Yang CT; Wang CC; Ou HT; Kuo S (PharmacoEconomics, 2025)